INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,673,889 | -20.0% | 242,691 | +3.2% | 0.04% | -15.1% |
| Q2 2023 | $9,592,638 | +49.8% | 235,229 | +36.9% | 0.05% | +43.2% |
| Q1 2023 | $6,405,000 | -1.3% | 171,879 | -8.3% | 0.04% | -7.5% |
| Q4 2022 | $6,492,000 | -40.5% | 187,365 | -3.9% | 0.04% | -43.7% |
| Q3 2022 | $10,915,000 | +6.0% | 195,063 | -2.0% | 0.07% | +9.2% |
| Q2 2022 | $10,301,000 | -38.8% | 199,032 | -14.0% | 0.06% | -24.4% |
| Q1 2022 | $16,824,000 | -37.3% | 231,517 | +4.6% | 0.09% | -27.1% |
| Q4 2021 | $26,843,000 | -13.5% | 221,404 | -4.3% | 0.12% | -15.7% |
| Q3 2021 | $31,030,000 | -28.0% | 231,312 | -13.1% | 0.14% | -24.3% |
| Q2 2021 | $43,087,000 | – | 266,123 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |